23 October 2013 - Deborah Wilkes
Archived
Novartis is reviewing the strategic options for its smaller businesses, including Consumer Health, which do not have "global scale and critical mass".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.